Preventive Medicine Doctors in Pleasanton, CA Accepting Medicare

7 Preventive Medicine doctors found. Showing 1 - 7

Dr. Chao Sun, M.D. Preventive Medicine - Occupational Medicine Medicare: May Accept Medicare Assignments Practice Location: 5700 Stoneridge Mall Rd Ste 100, Pleasanton, CA 94588 Phone: 925-915-9530

Dr. Stephen Reese Nord, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 5635 W Las Positas Blvd, Suite 401, Pleasanton, CA 94588 Phone: 925-520-0055    Fax: 925-520-0099

David Peter Discher, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 2781 Vista Diablo Ct, Pleasanton, CA 94566 Phone: 925-426-8264    Fax: 925-426-8264

Margaret C Ford, MD Preventive Medicine - Public Health & General Preventive Medicine Medicare: Medicare Enrolled Practice Location: 5311 Hopyard Rd, Pleasanton, CA 94588 Phone: 000-000-0000

Dr. Susan Piros Larson, MD, MPH Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 1020 Serpentine Ln Ste 115, Pleasanton, CA 94566 Phone: 650-954-0044

Ms. Diana Leigh Hasenpflug, ATC Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 1155 Santa Rita Rd, Pleasanton, CA 94566 Phone: 925-895-9244

Neetu S Trivedi, THERAPY DIR. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 5980 Stoneridge Dr Ste 100, Pleasanton, CA 94588 Phone: 925-847-8833

News Archive

Watson Laboratories sued over ANDA filing for generic Opana ER

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has been sued by Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-Release Tablets, 40mg.

Gore completes enrollment in study of VIABAHN Endoprosthesis with Heparin Bioactive Surface

W. L. Gore & Associates (Gore) reported the complete enrollment in a post-market approval study designed to better characterize the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in treating peripheral vascular disease (PVD) of the superficial femoral artery (SFA). The 11 participating sites enrolled a total of 120 patients in the Gore VIPER (GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface for SuPERficial Femoral Artery Endoluminal Bypass) Study since initiation.

Autism risk in children could be predicted by mutations in paternal sperm

Researchers from the University of California, San Diego, have found that mutations present in the sperms of the father could be predictors of autism in the offspring, in a landmark study. These mutations, if quantified could help ascertain the risk say the researchers. The new study appears this week in the latest issue of the journal Nature Medicine.

Hospice of the Western Reserve, Hospice of Dayton partner to provide quality care for all Ohioans

Ohio's two largest hospice care providers - Hospice of the Western Reserve and Hospice of Dayton - have announced a collaborative initiative to ensure delivery of the highest quality of care for all Ohioans. The partnership will focus on creating best practice standards for hospice and palliative care, proactively sharing quality data, benchmarking performance to continuously improve care delivery and creating the most skilled workforce.

Read more Medical News

› Verified 4 days ago